GLUE (STOCKS)
Monte Rosa Therapeutics, Inc. Common Stock
$15.840000
-0.110000 (-0.69%)
Prev close: $15.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Markus Warmuth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,401.45M
- Employees
- 142
- P/E (TTM)
- -8.31
- P/B (TTM)
- 2.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.43 | $-0.39 | -0.0412 | -10.60% |
|
Mar 2026 (Q1)
|
$-0.45 | $-0.39 | -0.0624 | -16.10% |
|
Dec 2025 (Q4)
|
$-0.56 | $-0.36 | -0.2014 | -56.16% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.38 | +0.0502 | +13.20% |
Financial Statements
| Income/Loss From Continuing Operations After Tax | -$161.09M |
| Income/Loss From Continuing Operations Before Tax | -$162.85M |
| Net Income/Loss | -$161.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$161.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$161.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $691.16M |
| Current Assets | $631.41M |
| Cash | $621.10M |
| Other Current Assets | $10.31M |
| Noncurrent Assets | $59.76M |
| Fixed Assets | $29.93M |
| Other Non-current Assets | $29.82M |
| Liabilities | $203.88M |
| Current Liabilities | $59.66M |
| Accounts Payable | $7.15M |
| Wages | $6.30M |
| Other Current Liabilities | $46.21M |
| Noncurrent Liabilities | $144.22M |
| Equity | $487.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $487.28M |
| Liabilities And Equity | $691.16M |
| Comprehensive Income/Loss | -$161.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$162.41M |
| Other Comprehensive Income/Loss | -$70.88M |